Product Reports Resources Pricing Login Book a demo

Exact Sciences

Biotech & Life Sciences · Madison, United States · Founded 1995 · IPO 2001

Developer and manufacturer of cologuard, a non-invasive screening test for the early detection of colorectal cancer

Valuation $22B
Revenue $3.25B
EBITDA $18M
Power Law Decacorn$10B+ valuation tier Thoroughbred$100M+ revenue
Knowledge graph
News Harbinger Health launches RESOLVE blood test with $100M to speed cancer diagnosis Apr 14, 2026

Talent graph

Exact Sciences's talent

Book a demo to see the people
Employees mapped 5,265 incl. 45 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 20 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Exact Sciences's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 5 investors entered at this stage
Highland Capital
Greylock Partners
OneLiberty Ventures
DCF Capital
Stan Lapidus
Series B+ 1 investor entered at this stage
Johns Hopkins University

Exact Sciences mafia

Startups founded by Exact Sciences alumni

Former Exact Sciences employees who went on to start their own companies. Sorted by Dealroom signal score.

Tessera TherapeuticsEst. 2018
Noubar AfeyanUnited States
Signal score63
Predictive BiosciencesEst. 2006
ASAnthony P. ShuberUnited States
Signal score60
SynapDxEst. 2010
Jeffery LuberUnited States
Signal score58
Gregor DiagnosticsEst. 2016
Tobias ZutzUnited States
Signal score55

Book a demo to explore the full alumni network →

Global footprint

Where Exact Sciences has talent and traffic

Workforce by country
26 countries with
team presence
🇺🇸 United States93.1%
🇨🇭 Switzerland1.3%
🇵🇱 Poland1.2%
🇩🇪 Germany0.7%
🇬🇧 United Kingdom0.7%
Top 5 of 26 shown
Web traffic by country
780K monthly visits
across markets
🇺🇸 United States94.9%
🇮🇳 India0.9%
🇨🇦 Canada0.5%
🇯🇵 Japan0.4%
🇲🇽 Mexico0.4%
Top 5 markets shown

Patent intelligence

$313M patent portfolio · 121 active families

Estimated portfolio value
$313M
1.5% of market cap · 7.6× smaller than top peer Illumina ($2.4B)
121 active patent families
Where Exact Sciences innovates BioinformaticsBiologyCancer researchCarcinosisDNA

Where Exact Sciences concentrates vs peers

Each axis is a top-10 topic across Exact Sciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Exact Sciences's 55 investments and acquisitions.

Every disclosed deal where Exact Sciences appeared as a backer or acquirer, 2017–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

55 deals across Exact Sciences's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Exact Sciences deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Exact Sciences's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        55 of 55 deals

        Market sentiment

        What the market is saying about Exact Sciences

        An AI-synthesized read of the highest-engagement posts about Exact Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Exact Sciences on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles